Was sind Omics?

• Literatur

• 1 Yadav SP. The wholeness in suffix -omics, -omes, and the word om. JBT 2007; 18: 277
• 2 Biomarkers Definitions Working Group. Biomarkers and surrogate endpoints: preferred definitions and conceptual framework. Clin Pharmacol Ther 2001; 69: 89-95
• 3 Kaddurah-Daouk R, Weinshilboum RM. Pharmacometabolomics Research Network. Pharmacometabolomics: implications for clinical pharmacology and systems pharmacology. Clin Pharmacol Ther 2014; 95: 154-167
• 4 Crettol S, de Leon J, Hiemke C et al. Pharmacogenomics in psychiatry: from therapeutic drug monitoring to genomic medicine. Clin Pharmacol Ther 2014; 95: 254-257
• 5 Doherty JL, Owen MJ. Genomic insights into the overlap between psychiatric disorders: implications for research and clinical practice. Genome medicine 2014; 6: 29
• 6 Kendler KS. What psychiatric genetics has taught us about the nature of psychiatric illness and what is left to learn. Molecular psychiatry 2013; 18: 1058-1066
• 7 Lehner T, Senthil G, Addington AM. Convergence of Advances in Genomics, Team Science, and Repositories as Drivers of Progress in Psychiatric Genomics. Biol Psychiatry 2014;
• 8 Smoller JW. Disorders and borders: psychiatric genetics and nosology. Am J Med Genet B Neuropsychiatr Genet 2013; 162B: 559-578
• 9 Psychiatric Genomics Consortium Im Internet: http://www.med.unc.edu/pgc/ (Stand: 15.10.2014)
• 10 Cross-Disorder Group of the Psychiatric Genomics Consortium. Lee SH, Ripke S, Neale BM et al. Genetic relationship between five psychiatric disorders estimated from genome-wide SNPs. Nat Genet 2013; 45: 984-994
• 11 Davis LK, Yu D, Keenan CL et al. Partitioning the heritability of Tourette syndrome and obsessive compulsive disorder reveals differences in genetic architecture. PLoS Genet 2013; 9: e1003864
• 12 McCarroll SA, Hyman SE. Progress in the genetics of polygenic brain disorders: significant new challenges for neurobiology. Neuron 2013; 80: 578-587
• 13 Lv J, Xin Y, Zhou W et al. The epigenetic switches for neural development and psychiatric disorders. Journal of genetics and genomics = Yi chuan xue bao 2013; 40: 339-346
• 14 Lasky-Su J. A network medicine approach to psychiatric genetics. Am J Med Genet B Neuropsychiatr Genet 2013; 162B: 579-586
• 15 Bennett DA, Yu L, Yang J et al. Epigenomics of Alzheimer's disease. Transl Res 2014;
• 16 Szyf M. Epigenetics, a key for unlocking complex CNS disorders? Therapeutic implications. Eur Neuropsychopharmacol 2014;
• 17 Voineagu I, Wang X, Johnston P et al. Transcriptomic analysis of autistic brain reveals convergent molecular pathology. Nature 2011; 474: 380-384
• 18 Uddin RK, Singh SM. Hippocampal gene expression meta-analysis identifies aging and age-associated spatial learning impairment (ASLI) genes and pathways. PloS one 2013; 8: e69768
• 19 Mirza Z, Kamal MA, Buzenadah AM et al. Establishing genomic/transcriptomic links between Alzheimer’s disease and type 2 diabetes mellitus by meta-analysis approach. CNS Neurol Disord Drug Targets 2014; 13: 501-516
• 20 Grünblatt E. The benefits of microarrays as tools for studying neuropsychiatric disorders. Drugs Today 2004; 40: 147-156
• 21 Grünblatt E, Bartl J, Zehetmayer S et al. Gene expression as peripheral biomarkers for sporadic Alzheimer's disease. J Alzheimers Dis 2009; 16: 627-634
• 22 Grünblatt E, Geissler J, Jacob CP et al. Pilot study: potential transcription markers for adult attention-deficit hyperactivity disorder in whole blood. Atten Defic Hyperact Disord 2012; 4: 77-84
• 23 Sequeira A, Turecki G. Genome wide gene expression studies in mood disorders. OMICS 2006; 10: 444-454
• 24 Seifuddin F, Pirooznia M, Judy JT et al. Systematic review of genome-wide gene expression studies of bipolar disorder. BMC Psychiatry 2013; 13: 213
• 25 Kumarasinghe N, Tooney PA, Schall U. Finding the needle in the haystack: a review of microarray gene expression research into schizophrenia. Aust N Z J Psychiatry 2012; 46: 598-610
• 26 Schwarz R, Reif A, Scholz CJ et al. A preliminary study on methylphenidate-regulated gene expression in lymphoblastoid cells of ADHD patients. World J Biol Psychiatry 2014; 1-10
• 27 Schwanhausser B, Busse D, Li N et al. Global quantification of mammalian gene expression control. Nature 2011; 473: 337-342
• 28 Vogel C, Marcotte EM. Insights into the regulation of protein abundance from proteomic and transcriptomic analyses. Nat Rev Genet 2012; 13: 227-232
• 29 Kim W, Bennett EJ, Huttlin EL et al. Systematic and quantitative assessment of the ubiquitin-modified proteome. Mol Cell 2011; 44: 325-340
• 30 Mabb AM, Ehlers MD. Ubiquitination in postsynaptic function and plasticity. Annu Rev Cell Dev Biol 2010; 26: 179-210
• 31 Craft GE, Chen A, Nairn AC. Recent advances in quantitative neuroproteomics. Methods 2013; 61: 186-218
• 32 Demartini DR, Schilling LP, da Costa JC et al. Alzheimer’s and Parkinson’s diseases: an environmental proteomic point of view. J Proteomics 2014; 104: 24-36
• 33 Nicholson JK, Lindon JC. Systems biology: Metabonomics. Nature 2008; 455: 1054-1056
• 34 Zhang A, Sun H, Wang X. Serum metabolomics as a novel diagnostic approach for disease: a systematic review. Anal Bioanal Chem 2012; 404: 1239-1245
• 35 Zhang AH, Sun H, Wang XJ. Recent advances in metabolomics in neurological disease, and future perspectives. Anal Bioanal Chem 2013; 405: 8143-8150
• 36 Trifonova O, Lokhov P, Archakov A. Postgenomics diagnostics: metabolomics approaches to human blood profiling. OMICS 2013; 17: 550-559
• 37 Kaddurah-Daouk R, Krishnan KR. Metabolomics: a global biochemical approach to the study of central nervous system diseases. Neuropsychopharmacology 2009; 34: 173-186
• 38 Gershon ES, Alliey-Rodriguez N. New ethical issues for genetic counseling in common mental disorders. Am J Psychiatry 2013; 170: 968-976
• 39 Korf BR, Rehm HL. New approaches to molecular diagnosis. JAMA 2013; 309: 1511-1521
• 40 Mathieu G, Groisman IJ, Godard B. Next generation sequencing in psychiatric research: what study participants need to know about research findings. Int J Neuropsychopharmacol 2013; 16: 2119-2127
• 41 Green RC, Berg JS, Grody WW et al. ACMG recommendations for reporting of incidental findings in clinical exome and genome sequencing. Genet Med 2013; 15: 565-574
• 42 Crawford G, Foulds N, Fenwick A et al. Genetic medicine and incidental findings: it is more complicated than deciding whether to disclose or not. Genet Med 2013; 15: 896-899
• 43 GPPC releases updated list of DTC genetic testing companies. Im Internet: http://www.dnapolicy.org/news.release.php?action=detail&pressrelease_id=145 (Stand: 15.10.2014)